Cadila, Cipla May See Pressure: CLSA
  • Prabha Hedge
  • Nov 19 2013

November 19: “We do not see improvement in headwinds for local pharma companies,” says, Hemant Bakhru, Pharmaceutical Investment Analyst, CLSA.